Small Signals, Strong Evidence: Mapping the Factors That Shape Abdominal Aortic Aneurysm Outcomes
en-GBde-DEes-ESfr-FR

Small Signals, Strong Evidence: Mapping the Factors That Shape Abdominal Aortic Aneurysm Outcomes

19/11/2026 HEP Journals

Abdominal aortic aneurysm is a life-threatening condition that often remains silent until rupture, and clinical management relies largely on aneurysm diameter. While traditional risk factors such as smoking and age are well established, the evidence on comorbidities, medications, biomarkers, and biomechanical parameters has remained fragmented. To address this gap, researchers conducted the first umbrella meta-analysis to integrate evidence across all major domains of AAA risk and protective factors. Following PRISMA 2020 guidelines, the team screened 2,081 records from PubMed and Embase and included 36 non-overlapping systematic reviews and meta-analyses, covering 49 exposure–outcome associations across 39 distinct factors related to AAA presence, growth, and rupture, with methodological quality appraised by AMSTAR-2 and evidence certainty graded by the GRADE system.

Several factors stood out with consistent protective signals. Diabetes was associated with lower AAA presence (OR 0.57), slower aneurysm growth (−0.25 mm/year), and lower rupture risk (OR 0.71). Statin use was linked to reduced aneurysm growth and a lower rupture risk (OR 0.63), supported by moderate-quality evidence, while metformin use was associated with slower aneurysm expansion. On the lifestyle side, higher physical activity was associated with reduced AAA presence, whereas obesity showed a positive association.

On the risk side, hypertension increased AAA incidence (RR 1.66). Among circulating biomarkers, D-dimer, fibrinogen, and hsCRP were positively associated with AAA presence, alongside elevations in IL-6, MMP-9, and the thrombin–antithrombin complex. Comorbidities including COPD, coronary artery disease, simple renal cysts, and primary abdominal wall hernia were also associated with higher AAA presence. In contrast, ARBs, beta-blockers, antiplatelet agents, and antibiotics showed no significant associations—and doxycycline, rather than being protective, was associated with a small increase in aneurysm growth. Biomechanically, the peak wall rupture index (PWRI) was positively associated with rupture risk.

The analysis confirms the multifactorial nature of AAA and establishes a clear evidence hierarchy—but it also shows that most factors lack high-quality evidence, and observational associations cannot establish causality. The authors offer conservative implications: statin therapy should follow established cardiovascular prevention indications in patients with AAA, metformin use in non-diabetic individuals remains investigational, and antibiotics are not recommended for AAA-specific risk management outside clinical trials. Standardized measurement and prospective studies are needed to improve risk prediction and therapeutic strategies.

The work titled “Associations of Comorbidities, Medications, Biomarkers, and Hemodynamic Factors with Abdominal Aortic Aneurysm Outcomes: An Umbrella Meta-Analysis” was published in Vascular Research (published on April 10, 2026).
DOI:10.15302/VR.2025.0007
Attached files
  • Image: Flow-chart of study selection.
19/11/2026 HEP Journals
Regions: Asia, China, North America, United States
Keywords: Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by AlphaGalileo Terms Of Use Privacy Statement